0001567619-21-014512.txt : 20210805
0001567619-21-014512.hdr.sgml : 20210805
20210805170138
ACCESSION NUMBER: 0001567619-21-014512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210805
DATE AS OF CHANGE: 20210805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lane Michael
CENTRAL INDEX KEY: 0001740689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 211149265
MAIL ADDRESS:
STREET 1: C/O IDEXX LABORATORIES, INC.
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2021-08-03
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001740689
Lane Michael
C/O IDEXX LABORATORIES, INC.
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
Common Stock
2021-08-03
4
M
0
1472
67.85
A
5119.2845
D
Common Stock
2021-08-03
4
M
0
1091
67.85
A
6210.2845
D
Common Stock
2021-08-03
4
M
0
4436
141.6
A
10646.2845
D
Common Stock
2021-08-03
4
S
0
2451
690.1997
D
8195.2845
D
Common Stock
2021-08-03
4
S
0
250
691.5368
D
7945.2845
D
Common Stock
2021-08-03
4
S
0
363
692.8467
D
7582.2845
D
Common Stock
2021-08-03
4
S
0
1447
693.7287
D
6135.2845
D
Common Stock
2021-08-03
4
S
0
916
694.7894
D
5219.2845
D
Common Stock
2021-08-03
4
S
0
100
695.5
D
5119.2845
D
Common Stock
2021-08-03
4
S
0
95
687.4650
D
5024.2845
D
Common Stock
2021-08-03
4
S
0
245
688.5444
D
4779.2845
D
Common Stock
2021-08-03
4
S
0
245
689.4310
D
4534.2845
D
Common Stock
2021-08-03
4
S
0
30
690.3250
D
4504.2845
D
Common Stock
2021-08-03
4
S
0
100
691.3520
D
4404.2845
D
Common Stock
2021-08-03
4
S
0
60
692.6466
D
4344.2845
D
Common Stock
2021-08-03
4
S
0
84
687.5931
D
4280.2845
D
Common Stock
2021-08-03
4
S
0
299
688.5104
D
3961.2845
D
Common Stock
2021-08-03
4
S
0
153
689.5101
D
3808.2845
D
Common Stock
2021-08-03
4
S
0
100
691.192
D
3708.2845
D
Common Stock
2021-08-03
4
S
0
60
692.5616
D
3648.2845
D
Common Stock
2021-08-03
4
S
0
1
693.17
D
3647.2845
D
Common Stock
592
I
by spouse
Incentive Stock Option (right-to-buy)
67.85
2021-08-03
4
M
0
1472
D
2026-02-13
Common Stock
1472
462
D
Non-Qualified Stock Option (right-to-buy)
67.85
2021-08-03
4
M
0
1091
D
2026-02-13
Common Stock
1091
0
D
Non-Qualified Stock Option (right-to-buy)
141.60
2021-08-03
4
M
0
4436
D
2027-02-13
Common Stock
4436
1512
D
Includes a total of 23.2845 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
Represents the weighted average sales price of the shares sold ranging from a low of $690.00 to a high of $690.965 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $691.085 to a high of $692.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $692.33 to a high of $693.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $693.38 to a high of $694.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $694.49 to a high of $695.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $686.91 to a high of $687.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $688.07 to a high of $688.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $689.14 to a high of $690 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $690.17 to a high of $690.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $691.19 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $692.27 to a high of $692.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $687.05 to a high of $687.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $688.09 to a high of $688.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $689.25 to a high of $690.18 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $690.45 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $692.125 to a high of $692.85 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
Grant of option to buy 2,072 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
Grant of option to buy 10,749 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
2021-08-05